Dr. Agarwal's Eye [DRAGARWQ] vs Shalby [SHALBY] Detailed Stock Comparison

Dr. Agarwal's Eye

BSE
Loading...

Shalby

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dr. Agarwal's Eye wins in 13 metrics, Shalby wins in 7 metrics, with 0 ties. Dr. Agarwal's Eye appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricDr. Agarwal's EyeShalbyBetter
P/E Ratio (TTM)40.351,122.67Dr. Agarwal's Eye
Price-to-Book Ratio11.142.59Shalby
Debt-to-Equity Ratio158.9447.82Shalby
PEG Ratio1.81-23.30Shalby
EV/EBITDA20.3227.20Dr. Agarwal's Eye
Profit Margin (TTM)13.96%-0.05%Dr. Agarwal's Eye
Operating Margin (TTM)22.71%8.44%Dr. Agarwal's Eye
EBITDA Margin (TTM)22.71%8.44%Dr. Agarwal's Eye
Return on Equity26.07%0.63%Dr. Agarwal's Eye
Return on Assets (TTM)8.91%0.37%Dr. Agarwal's Eye
Free Cash Flow (TTM)$-83.80M$-757.89MDr. Agarwal's Eye
Dividend Yield0.11%0.65%Shalby
1-Year Return4.92%-1.79%Dr. Agarwal's Eye
Price-to-Sales Ratio (TTM)5.642.57Shalby
Enterprise Value$26.43B$36.68BShalby
EV/Revenue Ratio6.383.32Shalby
Gross Profit Margin (TTM)77.64%39.66%Dr. Agarwal's Eye
Revenue per Share (TTM)$881$88Dr. Agarwal's Eye
Earnings per Share (Diluted)$123.07$-0.08Dr. Agarwal's Eye
Beta (Stock Volatility)-0.360.61Dr. Agarwal's Eye
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Dr. Agarwal's Eye vs Shalby Stock Performance Analysis

Loading Price Chart...

Dr. Agarwal's Eye
Shalby
Dr. Agarwal's Eye Stock Overview | Shalby Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dr. Agarwal's Eye-0.31%2.98%9.84%14.47%16.54%-23.53%
Shalby0.80%7.74%35.22%42.91%25.35%15.19%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dr. Agarwal's Eye4.92%358.10%1,895.43%3,647.65%6,296.19%14,656.04%
Shalby-1.79%99.07%178.07%11.12%11.12%11.12%

News Based Sentiment: Dr. Agarwal's Eye vs Shalby

Dr. Agarwal's Eye

News based Sentiment: POSITIVE

September was a strong month for Dr. Agarwal's, marked by impressive financial results, a commitment to shareholder returns through a 35% dividend, and increasing institutional investor confidence. Long-term projections from Walletinvestor.com further reinforce a positive investment outlook, suggesting significant potential for future growth.

View Dr. Agarwal's Eye News Sentiment Analysis

Shalby

News based Sentiment: MIXED

September presented a mixed bag for Shalby, with ambitious growth targets and a groundbreaking robotic surgery announcement offset by a decline in quarterly profits and cautious investor behavior. The insider buying provides a positive signal, but the overall picture is complex, requiring careful monitoring of execution and financial performance.

View Shalby News Sentiment Analysis

Performance & Financial Health Analysis: Dr. Agarwal's Eye vs Shalby

MetricDRAGARWQSHALBY
Market Information
Market Cap i₹23.46B₹28.58B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,4761,922,179
90 Day Avg. Volume i3,3611,363,786
Last Close₹4,950.65₹266.25
52 Week Range₹3,500.00 - ₹7,300.00₹177.25 - ₹278.15
% from 52W High-32.18%-4.28%
All-Time High₹7,300.00 (Dec 30, 2024)₹339.50 (Jan 22, 2024)
% from All-Time High-32.18%-21.58%
Growth Metrics
Quarterly Revenue Growth0.17%0.06%
Quarterly Earnings Growth0.22%-0.46%
Financial Health
Profit Margin (TTM) i0.14%0.00%
Operating Margin (TTM) i0.23%0.08%
Return on Equity (TTM) i0.26%0.01%
Debt to Equity (MRQ) i158.9447.82
Cash & Liquidity
Book Value per Share (MRQ)₹445.96₹101.79
Cash per Share (MRQ)₹52.76₹10.31
Operating Cash Flow (TTM) i₹738.70M₹-417,020,000
Levered Free Cash Flow (TTM) i₹546.50M₹62.22M
Dividends
Last 12-Month Dividend Yield i0.11%0.65%
Last 12-Month Dividend i₹5.00₹1.20

Valuation & Enterprise Metrics Analysis: Dr. Agarwal's Eye vs Shalby

MetricDRAGARWQSHALBY
Price Ratios
P/E Ratio (TTM) i40.351,122.67
Forward P/E i510.8828.05
PEG Ratio i1.81-23.30
Price to Sales (TTM) i5.642.57
Price to Book (MRQ) i11.142.59
Market Capitalization
Market Capitalization i₹23.46B₹28.58B
Enterprise Value i₹26.43B₹36.68B
Enterprise Value Metrics
Enterprise to Revenue i6.383.32
Enterprise to EBITDA i20.3227.20
Risk & Other Metrics
Beta i-0.360.61
Book Value per Share (MRQ) i₹445.96₹101.79

Financial Statements Comparison: Dr. Agarwal's Eye vs Shalby

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)DRAGARWQSHALBY
Revenue/Sales i₹1.17B₹2.96B
Cost of Goods Sold i₹261.40M₹1.79B
Gross Profit i₹907.80M₹1.18B
Research & Development iN/AN/A
Operating Income (EBIT) i₹265.50M₹250.15M
EBITDA i₹379.30M₹485.47M
Pre-Tax Income i₹231.90M₹226.53M
Income Tax i₹59.30M₹149.75M
Net Income (Profit) i₹172.60M₹76.78M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)DRAGARWQSHALBY
Cash & Equivalents i₹111.60M₹347.85M
Total Current Assets i₹559.40M₹6.58B
Total Current Liabilities i₹869.80M₹4.55B
Long-Term Debt i₹3.06B₹1.75B
Total Shareholders Equity i₹2.10B₹9.95B
Retained Earnings i₹1.99B₹4.44B
Property, Plant & Equipment i₹1.37B₹4.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)DRAGARWQSHALBY
Operating Cash Flow iN/A₹433.19M
Capital Expenditures iN/A₹-563.59M
Free Cash Flow iN/A₹-66.61M
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDRAGARWQSHALBY
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,4761,922,179
Average Daily Volume (90 Day) i3,3611,363,786
Shares Outstanding i4.70M107.27M
Float Shares i1.11M30.91M
% Held by Insiders i0.81%0.77%
% Held by Institutions i0.02%0.00%

Dividend Analysis & Yield Comparison: Dr. Agarwal's Eye vs Shalby

MetricDRAGARWQSHALBY
Last 12-Month Dividend i₹5.00₹1.20
Last 12-Month Dividend Yield i0.11%0.65%
3-Year Avg Annual Dividend i₹4.50₹1.08
3-Year Avg Dividend Yield i0.12%0.55%
3-Year Total Dividends i₹13.50₹3.23
Ex-Dividend DateNov 08, 2024Sep 19, 2024